Skip to main content
Caplight Logo









Mirae

Mirae

Private
LondonHealthcare & Life Scienceshttps://www.miraehealth.com/

Last Round

Seed

Jul 28, 2026

Total Funding Raised

$5.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Mirae is a health tech company that provides an AI-driven continuous care platform for managing autoimmune diseases and complex chronic conditions, starting with inflammatory bowel disease.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Patient Engagement, Vertical SaaS, Healthcare Analytics, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

chronic care managementpatient engagementdigital healthconversational AIclinical decision supportremote patient monitoringRPMhealthcare analyticsvertical SaaSAI scribepatient-reported outcomesPROclinical workflow automationhealth techAI copilot

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mirae Comparables

Compare Mirae with similar companies based on industry and business-model similarity.

Mirae comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SonarMD
76%
Salvo Health
76%
Orbita
59%

Mirae Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 28, 2026

Mirae Investors

Notable investors and investment history

Mirae investors
InvestorRounds
Oxford Science EnterprisesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    $5.4M round led by Oxford Science Enterprises

Recent news

Latest coverage and updates

  • receives_financingJul 28, 2026

    Miraehealth received financing of $5.4M in funding on Jul 28th '26.

Mirae Filings

Explore SEC and related filing metadata, where available.

Mirae filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mirae's valuation, stock price, and market status.

Is Mirae a public or private company?

Mirae is a private company.

What is the current stock price of Mirae?

Mirae is a private company with no public stock price. Caplight tracks Mirae's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Mirae worth (valuation)?

Valuation information for Mirae is not publicly available.

Can I buy Mirae stock?

Mirae shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mirae's last funding round?

Mirae's most recent funding round was Seed on July 28, 2026.

Who are the main investors in Mirae?

Key investors in Mirae include Oxford Science Enterprises.

Will Mirae IPO soon?

No public IPO plans have been announced for Mirae.

How can I track Mirae secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mirae's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Year Founded2026
Last FundingJul 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?